AACI Commentary

Reflections on the 2019 AACI/CCAF Annual Meeting

Save the Date

12th Annual AACI CRI Meeting

July 7-9, 2020
Chicago
Save the Date

2020 AACI/CCAF Annual Meeting

October 11-13, 2020
Kansas City
Share Your News

AACI Update

Cancer center submissions are due Wednesday, December 18 for the January AACI Update
 

Submit Your Stories

Latest News

AACI Update 
December 2019

Eliminating HPV-related Cancers
View the statement endorsed by AACI members 

The CLINICAL TREATMENT Act (H.R. 913)
Write your representatives
 

Our Mission

Working Together to Find a Cure

The Association of American Cancer Institutes (AACI) comprises 98 premier academic and freestanding cancer research centers in the U.S. and Canada. AACI is dedicated to reducing the burden of cancer by enhancing the impact of North America’s leading academic cancer centers.

CRI

Clinical
Research

Acting as a network for research leaders, Clinical Research Innovation (CRI) promotes the efficient operation of clinical research facilities at AACI cancer centers.

Discover CRI
Public Policy

Public
Policy

The AACI Government Relations Forum facilitates an improved understanding of policy issues as they pertain to cancer prevention, treatment, and survivorship.

Learn More
Meetings & Events

Meetings & Events

AACI meetings bring together cancer center leadership to find solutions to common challenges. AACI also shares event announcements as a benefit to members.
View Events

Recent Headlines

Congressional Budget Remains Uncertain Going Into 2020

Congressional Budget Remains Uncertain Going Into 2020

Read More
AACI, American Cancer Society, CDC Recognize HPV Vaccine Champions

AACI, American Cancer Society, CDC Recognize HPV Vaccine Champions

Read More
Sharpless Returns as NCI Director

Sharpless Returns as NCI Director

Read More

Meet the President

Roy A. Jensen, MD, has been the director of The University of Kansas Cancer Center since 2004. Under his leadership, KU Cancer Center earned designation from the National Cancer Institute in 2012.

Dr. Jensen has lectured widely on the clinical and molecular aspects of breast cancer pathology. His research focuses on understanding the function of BRCA1 and BRCA2 and their role in breast and ovarian neoplasia; and on the characterization of premalignant breast disease.

A member of AACI's board of directors since 2013, Dr. Jensen began his term as president in October 2018. 

AACI Board of Directors

Presidential Initiative

The AACI Presidential Initiative allows the president of AACI's Board of Directors to formalize a special project of broad interest and value to AACI members during their two-year term. Several of AACI's signature programs began as presidential initiatives.  

For his presidential initiative, Roy A. Jensen, MD, developed a comprehensive, cancer-specific library of model legislation and public policy resources. The AACI Public Policy Resource Librarywill address issues ranging from state funding for cancer research to HPV vaccination and tobacco regulation.
 

Learn More